NCT00508443
Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)
StatusActive, Not Recruiting
PhasePhase 1/2
SponsorM.D. Anderson Cancer Center
Primary completion (estimated)
At risk: Primary completion moved 2 years later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 32 versions: 24 with changes below, 8 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Oct 31, 2026 to Oct 31, 2028
- Eligibility criteria expanded, about 19 words
- Publications: details revised at 2 of 2 entries
- Notable Primary and study completion dates: Oct 31, 2024 to Oct 31, 2026v27
- Notable Primary and study completion dates: Oct 31, 2022 to Oct 31, 2024v25
- Notable Primary and study completion dates: Oct 31, 2021 to Oct 31, 2022v23
- Notable Primary and study completion dates: Oct 31, 2020 to Oct 31, 2021v22
Show 18 earlier versionsHide 18 earlier versions
- Notable Primary completion date: Oct 2019 to Oct 31, 2020
- Study completion date: Oct 2020 to Oct 31, 2020
- Start date: Oct 2002 to Oct 25, 2002
- Notable Primary completion date: Oct 2018 to Oct 2019
- Study completion date: Oct 2018 to Oct 2020
- Notable Primary completion date: Oct 2017 to Oct 2018
- Study completion date: Oct 2018
- Notable Primary completion date: Oct 2016 to Oct 2017v17
- Notable Primary completion date: Oct 2015 to Oct 2016
- Study site revised
- Notable Primary completion date: Oct 2014 to Oct 2015v15
- Notable Primary completion date: Oct 2013 to Oct 2014v14
- Notable Primary completion date: Oct 2012 to Oct 2013
- Eligibility criteria shortened, about 4 words
- Study description shortened, about 3 words
- Notable Primary completion date: Oct 2011 to Oct 2012v11
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised
- Minor Eligibility criteria expanded, about 4 wordsv9
- Minor Study site revisedv8
- Notable Primary completion date: Oct 2010 to Oct 2011v7
- Notable Primary endpoint revised
- Eligibility criteria revised
- Secondary endpoints shortened, about 27 words
- Notable Primary completion date: Oct 2009 to Oct 2010
- Secondary endpoints: details revised at 2 of 2 entries
- Minor Eligibility criteria revised
- Study description expanded, about 3 words
- Notable Primary endpoint revised
- Secondary endpoints revised (2)
- Study description expanded, about 1 word
- Minor Primary completion date: Oct 2009
- Interventions: Stereotactic Spine Radiotherapy (Procedure) to Radiation Therapy (Radiation)
- Study arms: 0 to 1
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Patient Response (Pain Relief)
Timeframe: Baseline, 3, 6, 9, 12, 18, and 24 months, then every six months
Arms and interventions
Radiation TherapyExperimental
Radiation Therapy using CT-on-Rails or Trilogy procedure. Participants prescribed to receive 9 Gy x 3 so that a peripheral dose of 27 Gy is given to the tumor.
Radiation: Radiation Therapy
Sites
1 site in 1 country
- University of Texas MD Anderson Cancer CenterHouston, Texas, United States